GlassScriptPhysician profile
Wallace B Sarver
NPI 1073524252
$3,165.28
in general payments reported to CMS, 2019-2025
34 companies · $265 in 2025
The $265 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $488 · 2020: $310 · 2021: $351 · 2022: $454 · 2023: $479 · 2024: $820 · 2025: $265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,055 · Travel and Lodging: $509.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,054.75 |
| Travel and Lodging | $508.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Histosonics, INC. | $508.95 | 2024 | |
| Glaxosmithkline, LLC. | $363.90 | 2019-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Abbott Laboratories | $331.54 | 2019-2025 | Freestyle Libre 3 |
| Pfizer INC. | $290.70 | 2019-2025 | |
| Abbvie INC. | $158.19 | 2021-2024 | Ubrelvy, Vraylar |
| Astrazeneca Pharmaceuticals LP | $155.57 | 2019-2024 | Airsupra, Farxiga |
| Novo Nordisk INC | $144.96 | 2019-2024 | Rybelsus, Ozempic |
| Merck Sharp & Dohme LLC | $126.16 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $118.03 | 2022-2024 | |
| Novartis Pharmaceuticals Corporation | $98.57 | 2022-2023 | |
| Astellas Pharma US INC | $90.23 | 2022-2023 | Veozah |
| Sanofi-Aventis U.S. LLC | $88.92 | 2019-2024 | |
| Lilly USA, LLC | $86.03 | 2019-2025 | Jardiance, Kisunla |
| Amarin Pharma, INC. | $77.94 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $74.96 | 2021-2023 | Livalo |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $49.94 | 2022-2024 | Intellis Adaptivestim |
| Optinose US, INC. | $45.10 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $36.70 | 2019-2024 | Xifaxan |
| Janssen Pharmaceuticals, INC | $36.36 | 2021-2025 | Spravato |
| Amgen INC. | $31.37 | 2020-2025 | Krystexxa |
| Dexcom, INC. | $23.85 | 2025 | Dexcom G6 Transmitter |
| Seqirus USA INC | $22.45 | 2025 | Fluad, Flucelvax |
| Xeris Pharmaceuticals, INC. | $22.37 | 2022 | |
| Dynavax Technologies Corporation | $21.10 | 2023 | Heplisav-B |
| Allergan, INC. | $19.84 | 2020 | |
| Vbi Vaccine (Delaware) INC. | $19.32 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $18.07 | 2022 | |
| Aytu Biopharma, INC. | $17.56 | 2020 | |
| Medtronic USA, INC. | $16.18 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.99 | 2020 | |
| Genentech USA, INC. | $14.64 | 2021 | |
| Sunovion Pharmaceuticals INC. | $13.91 | 2022 | |
| Currax Pharmaceuticals LLC | $13.86 | 2025 | Contrave |
| Amneal Pharmaceuticals LLC | $12.02 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wallace Sarver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.